105.01
price up icon0.10%   0.11
after-market Handel nachbörslich: 105.01
loading
Schlusskurs vom Vortag:
$104.90
Offen:
$104.94
24-Stunden-Volumen:
3.33M
Relative Volume:
1.03
Marktkapitalisierung:
$8.94B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-153.72M
KGV:
-52.51
EPS:
-2
Netto-Cashflow:
$-103.81M
1W Leistung:
+0.23%
1M Leistung:
+11.33%
6M Leistung:
+92.08%
1J Leistung:
+358.96%
1-Tages-Spanne:
Value
$104.87
$105.06
1-Wochen-Bereich:
Value
$104.71
$105.30
52-Wochen-Spanne:
Value
$18.51
$105.30

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Name
Firmenname
Verona Pharma Plc Adr
Name
Telefon
011-44-0-2032834200
Name
Adresse
3 MORE LONDON RIVERSIDE, LONDON
Name
Mitarbeiter
209
Name
Twitter
@VeronaPharma
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
VRNA's Discussions on Twitter

Vergleichen Sie VRNA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VRNA
Verona Pharma Plc Adr
105.01 8.92B 0 -153.72M -103.81M -2.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-07-14 Herabstufung H.C. Wainwright Buy → Neutral
2025-07-01 Eingeleitet Wolfe Research Outperform
2025-04-28 Eingeleitet TD Cowen Buy
2025-04-21 Eingeleitet Cantor Fitzgerald Overweight
2025-01-10 Eingeleitet ROTH MKM Buy
2024-10-03 Eingeleitet Wells Fargo Overweight
2023-05-22 Fortgesetzt Jefferies Buy
2022-09-19 Fortgesetzt Wedbush Outperform
2022-08-26 Eingeleitet Piper Sandler Overweight
2021-09-13 Eingeleitet H.C. Wainwright Buy
2020-08-25 Eingeleitet Jefferies Buy
2020-08-10 Eingeleitet Canaccord Genuity Buy
2019-04-18 Eingeleitet BTIG Research Buy
Alle ansehen

Verona Pharma Plc Adr Aktie (VRNA) Neueste Nachrichten

pulisher
Jul 19, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, DALN, RGLD on Behalf of Shareholders - GlobeNewswire Inc.

Jul 19, 2025
pulisher
Jul 18, 2025

Verona Pharma stock reaches all-time high at 105.0 USD By Investing.com - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Verona Pharma stock reaches all-time high at 105.0 USD - Investing.com Australia

Jul 18, 2025
pulisher
Jul 14, 2025

Merck to Acquire Verona Pharma in $10 Billion Deal to Expand Respiratory Drug Portfolio - MSN

Jul 14, 2025
pulisher
Jul 14, 2025

Pharmaceutical Stocks To Research – July 12th - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Top Medical Stocks To Follow Now – July 12th - Defense World

Jul 14, 2025
pulisher
Jul 11, 2025

Wells Fargo Downgrades Verona Pharma plcDepositary Receipt () (VRNA) - MSN

Jul 11, 2025
pulisher
Jul 10, 2025

Merck stock rises as UBS reiterates Buy rating after Verona Pharma acquisition By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Merck to acquire Verona Pharma stock for $107 per ADS in $10 billion deal By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Verona Pharma stock rating downgraded to Neutral by Roth/MKM after Merck offer - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Merck to Acquire Verona Pharma for $10 Billion in Bid to Cushion "Patent Cliff" Impact - Mitrade

Jul 10, 2025
pulisher
Jul 10, 2025

Verona Pharma stock hits all-time high at 104.83 USD By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 09, 2025

American pharmaceutical company Merck acquires British Verona Pharma for $10 billion - AKM.RU

Jul 09, 2025
pulisher
Jul 09, 2025

Verona Pharma stock hits all-time high at 104.83 USD - Investing.com

Jul 09, 2025
pulisher
Jul 09, 2025

Verona Pharma Stock Jumps 20% on $10B Buyout Offer From Merck - Nasdaq

Jul 09, 2025
pulisher
Jul 09, 2025

Merck to acquire Verona Pharma for $10 billion By Investing.com - Investing.com Nigeria

Jul 09, 2025
pulisher
Jul 09, 2025

Merck dives into COPD treatments with $10 billion purchase of Verona Pharma - MarketWatch

Jul 09, 2025
pulisher
Jul 09, 2025

Merck to acquire Verona Pharma for $10 billion - Investing.com Australia

Jul 09, 2025
pulisher
Jul 09, 2025

Can Verona Pharma Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

Jul 09, 2025
pulisher
Jul 09, 2025

Starbucks, Freeport-McMoran and Verona Pharma rise premarket; WPP, T-Mobile fall By Investing.com - Investing.com South Africa

Jul 09, 2025
pulisher
Jul 09, 2025

Merck compra por 10.000 millones de dólares Verona Pharma - Yahoo Finanzas

Jul 09, 2025
pulisher
Jul 07, 2025

Best Momentum Stock To Buy For July 7th - Barchart.com

Jul 07, 2025
pulisher
Jul 02, 2025

Apellis Stock Rises on $300M Royalty Deal With Sobi for Aspaveli - Yahoo Finance

Jul 02, 2025
pulisher
Jun 24, 2025

Up 515%, Watch This Biopharma Breakout - inkl

Jun 24, 2025
pulisher
Jun 10, 2025

Verona Pharma: A Blockbuster Franchise In The Making - Seeking Alpha

Jun 10, 2025
pulisher
Jun 05, 2025

Investing $15,000 Into Each of These 3 Stocks 5 Years Ago Would Have Created a Portfolio Worth $1 Million Today - Barchart.com

Jun 05, 2025
pulisher
Jun 02, 2025

21 Best-Performing Small-Cap Stocks for June 2025 - NerdWallet

Jun 02, 2025
pulisher
May 29, 2025

Verona Pharma ADR Surges, Matches Key 52-Week High: What’s Fueling the Rally? - Daily Chhattisgarh News

May 29, 2025
pulisher
May 29, 2025

Verona Pharma stock soars to all-time high of $77.08 By Investing.com - Investing.com Nigeria

May 29, 2025
pulisher
May 23, 2025

FDA Approves GSK's Nucala for Expanded Use in COPD - Zacks Investment Research

May 23, 2025
pulisher
May 20, 2025

Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart

May 20, 2025
pulisher
May 20, 2025

Verona Pharma stock soars to all-time high of $74.36 By Investing.com - Investing.com UK

May 20, 2025
pulisher
May 08, 2025

Market Update: Verona Pharma Plc ADR (VRNA) Sees Negative Movement, Closing at 69.14 - DWinneX

May 08, 2025
pulisher
May 08, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA): An Enticing Stock To Watch - Stocksregister

May 08, 2025
pulisher
May 06, 2025

IBD Stock Of The Day Verona Pharma Tests Buy Point After Earnings Breakout - Investor's Business Daily

May 06, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Verona Pharma director Vikas Sinha sells $178,416 in stock By Investing.com - Investing.com South Africa

May 01, 2025
pulisher
May 01, 2025

Verona Pharma’s general counsel sells shares worth $234,126 - Investing.com

May 01, 2025
pulisher
May 01, 2025

Verona Pharma Plc ADR (VRNA)’s Market Momentum: Closing Strong at 72.07, Down -1.56 - DWinneX

May 01, 2025
pulisher
Apr 30, 2025

What is Verona Pharma Plc ADR (VRNA) Stock Return on Shareholders’ Capital? - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Verona Pharma Plc ADR [VRNA] Stock trading around $73.21 per share: What’s Next? - dbtnews.com

Apr 30, 2025
pulisher
Apr 29, 2025

VRNA’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Apr 29, 2025
pulisher
Apr 29, 2025

Watch this stock’s price performance: Verona Pharma Plc ADR (NASDAQ:VRNA) - uspostnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Verona Pharma ADR earnings beat by $0.05, revenue topped estimates - Investing.com UK

Apr 29, 2025
pulisher
Apr 28, 2025

Verona Pharma Plc ADR (NASDAQ: VRNA) Could Soar To Much Higher Prices In Coming Months - Marketing Sentinel

Apr 28, 2025
pulisher
Apr 28, 2025

TD Cowen starts Verona Pharma stock at Buy, sets $100 target - Investing.com

Apr 28, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Shareholders Approve All Proposals at AGM - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Verona Pharma Plc ADR (VRNA) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Is Astrazeneca plc ADR (AZN) positioned for future growth? - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Verona Pharma Plc ADR [VRNA] Records 50-Day SMA of $62.73 - knoxdaily.com

Apr 25, 2025

Finanzdaten der Verona Pharma Plc Adr-Aktie (VRNA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):